サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：細胞分離技術の世界市場：2023-2030年
市場調査レポート
商品コード
1380421

細胞分離技術の世界市場：2023-2030年

Global Cell Separation Technology Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 200 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.94円
細胞分離技術の世界市場：2023-2030年
出版日: 2023年09月27日
発行: Orion Market Research
ページ情報: 英文 200 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞分離技術市場は予測期間（2023-2030年）にCAGR 10.1％で成長すると予測されています。細胞分離技術は、幹細胞や腫瘍学の研究から日常的な臨床診断まで、多くのライフサイエンスにおいて重要な役割を担っています。多くの分野にわたる発展に伴い、イメージング技術とスペクトル技術の採用が拡大していることが、世界の市場の成長を支える主な要因です。研究者は、新しいモジュール式光学アーキテクチャとシステムを考慮したアルゴリズムによって実現される拡張性能と相まって、簡素化されたワークフローでハイパラメータ実験を行うフルスペクトル細胞ソーティングを達成することができます。したがって、市場プレーヤーは、市場成長をさらに強化する細胞選別装置ソリューションの導入にも注力しています。例えば、2023年5月、医療技術企業であるBD（ベクトン・ディッキンソン・アンド・カンパニー）は、研究者が細胞のより詳細な情報を明らかにすることを可能にする2つの画期的な技術を搭載した新しい細胞選別装置を発売しました。BDセルビュー（TM）イメージテクノロジーにより、研究者は個々の細胞の詳細な顕微鏡画像を見ることができ、視覚的特徴に基づいて高速で選別し、リアルタイムで洞察を確認することができます。

セグメンテーションの展望

磁気活性化細胞分離システムは世界の細胞分離技術市場で大きなシェアを占めると予想されます。

種類別では、磁気活性化細胞分離システムのサブセグメントが世界の細胞分離技術市場でかなりのシェアを占めると予想されます。このセグメントの成長は、生物学的懸濁液から目的の細胞集団を分離するための磁気細胞分離の影響力の高まりに起因しており、生物医学における診断や治療から、環境アプリケーションや生物学における基礎研究まで、幅広い用途をカバーしています。研究者は今、前例のないサンプル処理能力と洞察力で発見を加速することができます。磁気浮上によって目的の細胞を分離・濃縮する、穏やかで高速かつ偏りのない新しい方法。例えば、2022年4月、LevitasBio, Inc.は、細胞分離と濃縮のための次世代ソリューションであるLeviCell（TM）EOSシステムを発売しました。

地域別展望

世界の細胞分離技術市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。なかでも北米は、先進的な技術ソリューションの採用により、世界市場で突出したシェアを占めると予想されています。さらに、細胞治療分野における研究大学による広範な研究活動が、細胞分離ソリューションに対する大きな需要を生み出しています。

アジア太平洋地域は世界の細胞分離技術市場において著しいCAGRで成長すると予想されます。

すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予想されています。この地域の成長は、中国やインドなどの新興経済国における製薬およびバイオテクノロジー産業の成長に起因しています。さらに、日本、中国、韓国における継続的な幹細胞や遺伝子治療研究の取り組みが、この地域における細胞分離ソリューションの需要を押し上げています。同地域における慢性疾患の有病率の増加は、細胞分離技術の成長の主な促進要因です。国立衛生研究所（NIH）によると、2022年3月、インドの高齢者の約21.0％が少なくとも1つの慢性疾患を抱えていると報告されています。農村部では17.0%、都市部では29.0%の高齢者が慢性疾患に苦しんでいます。

ヒトとがん研究への注目の高まり、バイオ医薬品開発、臨床試験、研究における分離ヒト細胞の多様な応用は、市場成長の主な要因のひとつです。さらに、先進国における個別化医療に関する有利な償還政策がヒト細胞単離の需要を押し上げています。主な市場プレイヤーは、ソニーバイオテクノロジー、Miltenyi Biotec Japan、Himedia Laboratories、Magcrown Biotech、Sinobioway Biomedicine、NanoEntek、Bioneer Corpなどです。

決定

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Genscript Biotech Corp.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Merck KGaA
    • Oerview
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Thermo Fisher Scientific Inc.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • 細胞分離技術の世界市場：タイプ別
    • 装置
      • 遠心分離機
      • フローサイトメーター
      • ろ過システム
      • 磁気活性化細胞分離システム
    • 消耗品
      • 試薬、キット、培地、血清
      • ビーズ
      • 消耗品
  • 細胞分離技術の世界市場：技術別
    • 勾配遠心分離
    • 表面マーカー分離
    • ろ過ベースの分離
    • 免疫密度細胞分離
    • その他（マイクロ流体細胞分離）
  • 細胞分離技術の世界市場：用途別
    • 腫瘍学
    • 神経科学
    • 幹細胞研究
    • 微生物学
    • 免疫学
  • 細胞分離技術の世界市場：エンドユーザー別
    • 研究機関・研究所
    • バイオテクノロジー・バイオ製薬会社
    • 病院・診断研究所

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Akadeum Life Sciences, Inc.
  • Alfa-Laval AB
  • Applied Cells Inc.
  • Biocompare, Inc.
  • BioProcess International（TM）
  • Cell Microsystems.
  • Corning Inc.
  • Cytiva Life Science
  • Elvesys group
  • ESI Technologies Group
  • IBA Lifesciences GmbH
  • Miltenyi Biotec
  • NanoCellect Biomedical, Inc.
  • pluriSelect Life Science
  • Proteintech Group
  • QIAGEN N.V.
  • STEMCELL Technologies Inc.
  • Techne Corp.
図表

LIST OF TABLES

  • 1. GLOBAL CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL INSTRUMENTS FOR CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL CONSUMABLES FOR CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 5. GLOBAL GRADIENT CENTRIFUGATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SURFACE MARKERS SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL FILTRATION BASED SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL IMMUNODENSITY CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL OTHER CELL SEPARATION TECHNOLOGIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CELL SEPARATION TECHNOLOGY IN ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CELL SEPARATION TECHNOLOGY IN NEUROSCIENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL CELL SEPARATION TECHNOLOGY IN STEM CELL RESEARCH MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL CELL SEPARATION TECHNOLOGY IN MICROBIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. GLOBAL CELL SEPARATION TECHNOLOGY IN IMMUNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 17. GLOBAL CELL SEPARATION TECHNOLOGY FOR RESEARCH LABORATORIES & INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. GLOBAL CELL SEPARATION TECHNOLOGY FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. GLOBAL CELL SEPARATION TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 20. GLOBAL CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 23. NORTH AMERICAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 24. NORTH AMERICAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 25. NORTH AMERICAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 26. EUROPEAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. EUROPEAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 28. EUROPEAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 29. EUROPEAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 30. EUROPEAN CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 31. ASIA- PACIFIC CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 32. ASIA- PACIFIC CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 33. ASIA- PACIFIC CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. ASIA- PACIFIC CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 35. ASIA- PACIFIC CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)
  • 36. REST OF THE WORLD CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 37. REST OF THE WORLD CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 38. REST OF THE WORLD CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 39. REST OF THE WORLD CELL SEPARATION TECHNOLOGY MARKET RESEARCH AND ANALYSIS BY END USERS, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CELL SEPARATION TECHNOLOGY MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL INSTRUMENTS FOR CELL SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL CELL SEPARATION CENTRIFUGES TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL CELL SEPARATION FLOW CYTOMETERS TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL CELL SEPARATION FILTRATION SYSTEMS TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL CELL SEPARATION MAGNETIC-ACTIVATED CELL SEPARATOR SYSTEMS TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL CONSUMABLES CELL SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL CELL SEPARATION REAGENTS, KITS, MEDIA, AND SERA TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL CELL SEPARATION BEADS TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL CELL SEPARATION DISPOSABLES TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL CELL SEPARATION TECHNOLOGY MARKET SHARE BY TECHNOLOGY, 2022 VS 2030 (%)
  • 12. GLOBAL GRADIENT CENTRIFUGATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SURFACE MARKERS SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL FILTRATION BASED SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL IMMUNODENSITY CELL SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 16. GLOBAL OTHER CELL SEPARATION TECHNOLOGIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL CELL SEPARATION TECHNOLOGY MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 18. GLOBAL CELL SEPARATION TECHNOLOGY IN ONCOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. GLOBAL CELL SEPARATION TECHNOLOGY IN NEUROSCIENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 20. GLOBAL CELL SEPARATION TECHNOLOGY IN STEM CELL RESEARCH MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 21. GLOBAL CELL SEPARATION TECHNOLOGY IN MICROBIOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 22. GLOBAL CELL SEPARATION TECHNOLOGY IN IMMUNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 23. GLOBAL CELL SEPARATION TECHNOLOGY MARKET SHARE BY END USER, 2022 VS 2030 (%)
  • 24. GLOBAL CELL SEPARATION TECHNOLOGY FOR RESEARCH LABORATORIES & INSTITUTES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 25. GLOBAL CELL SEPARATION TECHNOLOGY FOR BIOTECHNOLOGY & BIOPHARMACEUTICAL COMPANIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 26. GLOBAL CELL SEPARATION TECHNOLOGY FOR HOSPITALS & DIAGNOSTIC LABORATORIES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 27. GLOBAL CELL SEPARATION TECHNOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 28. US CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. CANADA CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. UK CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. FRANCE CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. GERMANY CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 33. ITALY CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 34. SPAIN CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 35. REST OF EUROPE CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 36. INDIA CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 37. CHINA CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 38. JAPAN CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 39. SOUTH KOREA CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 40. REST OF ASIA-PACIFIC CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
  • 41. REST OF THE WORLD CELL SEPARATION TECHNOLOGY MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027830

Title: Global Cell Separation Technology Market Size, Share & Trends Analysis Report by Type (Instruments and Consumables), by Technology (Gradient Centrifugation, Surface Markers Separation, Filtration Based Separation, Immunodensity Cell Separation, and Others), by Application (Oncology, Neuroscience, Stem Cell Research, Microbiology, and Immunology), and by End Users (Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies and Hospitals & Diagnostic Laboratories)Forecast Period (2023-2030).

The global cell separation technology market is anticipated to grow at a CAGR of 10.1% during the Forecast Period (2023-2030). Cell separation technology is a key part of many life sciences, from stem cell and oncology research to routine clinical diagnosis. The growing adoption of imaging and spectral technologies with the development across numerous fields is the key factor supporting the growth of the market globally. Researchers can achieve full-spectrum cell sorting, coupled with expanded performance enabled by a new modular optical architecture and system-aware algorithms, to perform high-parameter experiments within a simplified workflow. Hence, the market players are also focusing on introducing cell sorting instrument solutions that further bolster the market growth. For instance, in May 2023, BD (Becton, Dickinson and Company), A medical technology company, launched a new cell sorting instrument featuring two breakthrough technologies that enable researchers to uncover more detailed information about cells. With BD CellView™ Image Technology, researchers can see detailed microscopic images of individual cells and sort at high speeds based on visual characteristics to confirm insights in real time.

Segmental Outlook

The global cell separation technology market is segmented on the type, technology, application and end users. Based on the type, the market is sub-segmented into Instruments (centrifuges, flow cytometers, filtration systems, magnetic-activated cell separator systems) and consumables (reagents, kits, media, and sera, beads, disposables). Based on the technology, the market is sub-segmented into gradient centrifugation, surface markers separation, filtration-based separation, immunodensity cell separation and others (microfluidic cell separation). Based on the application, the market is sub-segmented into oncology, neuroscience, stem cell research, microbiology and immunology. Further, on the basis of end user, the market is sub-segmented into research laboratories & institutes, biotechnology & biopharmaceutical companies and hospitals & diagnostic laboratories. Among the technology, the gradient centrifugation sub-segment is anticipated to hold a considerable share of the market owing to the rise in development of gradient centrifugation that frequently employed techniques in the molecular biology laboratory. Centrifugation is used to collect cells, to precipitate DNA, to purify virus particles, and to distinguish subtle differences in the conformation of molecules.

The Magnetic-Activated Cell Separator Systems Sub-Segment is Anticipated to Hold a Considerable Share of the Global Cell Separation Technology Market

Among the type, the magnetic-activated cell separator systems sub-segment is expected to hold a considerable share of the global cell separation technology market. The segmental growth is attributed to the growing influence of the magnetic cell separation for the isolation of target cell populations from biological suspensions, covering a wide spectrum of applications from diagnosis and therapy in biomedicine to environmental applications or fundamental research in biology. Researchers can now accelerate their discoveries with unprecedented sample processing power and insights. A new gentle, fast, and unbiased method to separate and enrich cells of interest via magnetic levitation. For instance, in April 2022, LevitasBio, Inc. launched the LeviCell™ EOS System, their next-generation solution for cell separation and enrichment, featuring higher throughput and simultaneous targeted selection of viable cells.

Regional Outlook

The global cell separation technology market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America is anticipated to hold a prominent share of the market across the globe, owing to the adoption of advanced technologically solutions. Furthermore, extensive research activities by research universities in the field of cell therapies have created a huge demand for cell separation solutions.

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Cell Separation Technology Market

Among all regions, the Asia-Pacific regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to growing pharmaceutical and biotechnology industries in emerging economies, such as China and India. Furthermore, continuous stem and gene therapy research initiatives in Japan, China, and South Korea have boosted the demand for cell separation solutions in the region. An increase in the prevalence of chronic disease in the region is the major driving factor for the growth of cell separation technology. According to the National Institute of Health (NIH), in March 2022, About 21.0% of the elderly in India reportedly have at least one chronic disease. 17.0% elderly in rural areas and 29.0% in urban areas suffer from a chronic diseases.

The rising focus on human & cancer research and varied applications of isolated human cells in biopharmaceutical development, clinical trials, and research are among the major factors contributing to market growth. Moreover, favorable reimbursement policies pertaining to personalized medicine in developed countries boost the demand for human cell isolation. The key market players include Sony Biotechnology, Miltenyi Biotec Japan, Himedia Laboratories, Magcrown Biotech, Sinobioway Biomedicine, NanoEntek, Bioneer Corp and others.

Done

Market Players Outlook

The major companies serving the global cell separation technology market include: Corning Inc., Genscript Biotech Corp., Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in April 2022, Applied Cells Inc. and STEMCELL Technologies Inc. collaborated to deliver a new high-performance cell separation solution that combines Applied Cells' MARS® platform with STEMCELL's EasySep™ immunomagnetic cell separation kits. This partnership helps researchers around the world to automate and increase the efficiency of isolating high-quality cells from a wide range of sample types.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cell separation technology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Genscript Biotech Corp.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Merck KGaA
    • 3.3.1. Oerview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Thermo Fisher Scientific Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Cell Separation Technology Market by Type
    • 4.1.1. Instruments
      • 4.1.1.1. Centrifuges
      • 4.1.1.2. Flow Cytometers
      • 4.1.1.3. Filtration Systems
      • 4.1.1.4. Magnetic-activated Cell Separator Systems
    • 4.1.2. Consumables
      • 4.1.2.1. Reagents, Kits, Media, and Sera
      • 4.1.2.2. Beads
      • 4.1.2.3. Disposables
  • 4.2. Global Cell Separation Technology Market by Technology
    • 4.2.1. Gradient Centrifugation
    • 4.2.2. Surface Markers Separation
    • 4.2.3. Filtration Based Separation
    • 4.2.4. Immunodensity Cell Separation
    • 4.2.5. Others (Microfluidic Cell Separation)
  • 4.3. Global Cell Separation Technology Market by Application
    • 4.3.1. Oncology
    • 4.3.2. Neuroscience
    • 4.3.3. Stem Cell Research
    • 4.3.4. Microbiology
    • 4.3.5. Immunology
  • 4.4. Global Cell Separation Technology Market by End Users
    • 4.4.1. Research Laboratories & Institutes
    • 4.4.2. Biotechnology & Biopharmaceutical Companies
    • 4.4.3. Hospitals & Diagnostic Laboratories

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Akadeum Life Sciences, Inc.
  • 6.2. Alfa-Laval AB
  • 6.3. Applied Cells Inc.
  • 6.4. Biocompare, Inc.
  • 6.5. BioProcess International™
  • 6.6. Cell Microsystems.
  • 6.7. Corning Inc.
  • 6.8. Cytiva Life Science
  • 6.9. Elvesys group
  • 6.10. ESI Technologies Group
  • 6.11. IBA Lifesciences GmbH
  • 6.12. Miltenyi Biotec
  • 6.13. NanoCellect Biomedical, Inc.
  • 6.14. pluriSelect Life Science
  • 6.15. Proteintech Group
  • 6.16. QIAGEN N.V.
  • 6.17. STEMCELL Technologies Inc.
  • 6.18. Techne Corp.